Biolife Solutions Inc. logo

Biolife Solutions Inc. (BLFS)

Market Closed
24 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
22. 26
-0.19
-0.85%
$
993.06M Market Cap
- P/E Ratio
0% Div Yield
397,552 Volume
-1.02 Eps
$ 22.45
Previous Close
Day Range
22.03 22.95
Year Range
19.1 29.55
Want to track BLFS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 13 days
BioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call Transcript

BioLife Solutions, Inc. (NASDAQ:BLFS ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Rod de Greef - Chairman and Chief Executive Officer Garrie Richardson - Chief Revenue Officer Conference Call Participants Matt Stanton - Jefferies Brendan Smith - TD Cowen Anna Snopkowski - KeyBanc Matt Hewitt - Craig-Hallum Capital Group LLC Thomas Flaten - Lake Street Capital Markets Jade Montgomery - H.C. Wainwright & Co., LLC Operator Good afternoon, ladies and gentlemen, and thank you for standing by.

Seekingalpha | 8 months ago
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.67 per share a year ago.

Zacks | 8 months ago
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Here is how BioLife Solutions, Inc. (BLFS) and Eli Lilly (LLY) have performed compared to their sector so far this year.

Zacks | 9 months ago
Here's Why Momentum in BioLife Solutions (BLFS) Should Keep going

Here's Why Momentum in BioLife Solutions (BLFS) Should Keep going

BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks | 9 months ago
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Here is how BioLife Solutions, Inc. (BLFS) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Zacks | 10 months ago
BioLife Is Cleaning Ship

BioLife Is Cleaning Ship

BioLife was overextended on acquisitions, leading to margin compression and dilution of shareholder capital. The company has divested from non-core businesses, focusing on preservation media where it is a market leader. Improved financial results include gross margin expansion, lower OpEx, and increased revenue guidance, driven by growth in the Cell Processing business.

Seekingalpha | 11 months ago
BioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call Transcript

BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Troy Wichterman – Chief Financial Officer Rod de Greef – Chairman and Chief Executive Officer Garrie Richardson – Chief Revenue Officer Conference Call Participants Jacob Johnson – Stephens Anna Snopkowski – KeyBanc Matt Stanton – Jefferies Steven Mah – TD Cowen Thomas Flaten – Lake Street Capital Markets Operator Good afternoon, and welcome to the BioLife Solutions Q2 2024 Shareholder and Analyst Conference Call. [Operator Instructions] Please note, this event is being recorded.

Seekingalpha | 11 months ago
BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.23 per share a year ago.

Zacks | 11 months ago
What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing'

What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing'

BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks | 1 year ago
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase

BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase

BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.

Zacks | 1 year ago